Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases
- Authors: Moiseeva OM1, Mitrofanova LB1, Nakatseva EV1, Zverev DA1, Skurydin SV2, Poletaev AB2
-
Affiliations:
- Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
- Медицинский исследовательский центр "Иммункулус", Москва
- Issue: Vol 84, No 9 (2012)
- Pages: 47-52
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31100
- ID: 31100
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
O M Moiseeva
Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
Email: omoiseeva@front.ru
197341, Санкт-Петербург, ул. Аккуратова, 2
L B Mitrofanova
Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
Email: lubamitr@rambler.ru
E V Nakatseva
Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
D A Zverev
Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
Email: dmitry_zverev@rambler.ru
S V Skurydin
Медицинский исследовательский центр "Иммункулус", Москва
A B Poletaev
Медицинский исследовательский центр "Иммункулус", Москва
Email: a-b-poletaev@yandex.ru
References
- Yoshikawa T., Baba A., Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 2009; 73 (4): 602-607.
- Ehrlich P., Morgenroth J. Zytotoxine als Antikorper. Berl Klin Wochenschr 1901; 38: 251-260.
- Metchnokoff E. Immunity in infective diseases. (Original published 1901). New York: Johnson Reprint; 1968.
- Полетаев А.Б. Физиологическая иммунология (естественные аутоантитела и проблемы наномедицины). М: МИКЛОШ 2010; 218.
- Мальцев С.В., Полетаев А.Б., Мансурова Г.Ш. Диагностическое и прогностическое определение естественных ауто-АТ к почечным антигенам в развитии пиелонефрита у детей. Педиатрия 2007; 86 (6): 60-64.
- Скурыдин С.В., Широхова Н.М., Карабиненко А.А., Куприянов А.Н. Клинико-диагностическое значение изучения содержания пульмотропных аутоантител на модели внебольничной пневмонии у пациентов пожилого и старческого возраста. Рос иммунол журн 2010; 1: 60-67.
- Cooper L.T., Baughman K.L., Feldmann A.M. et al. The role of endomyocardial biopsy in the management of cardiovascular disease. Eur Heart J 2007; 28 (24): 3076-3093.
- Poletaev A.B., Abrosimova A.A., Sokolov M.A. et al. Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol 2004; 11 (2): 151-156.
- Quintana F.J., Getz G., Hed G. et al. Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. J Autoimmun 2003; 21 (1): 65-75.
- Meroni P.L., De Angeles V., Tedesco F. Future trends. In: Y. Shoenfeld, Gershwin M. E., Meroni P.L., eds. Autoantibodies. Amsterdam: Elsevier 2007: 823-826.
- Magnani J.W., Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113 (6): 876-890.
- Tsai S., Chu S., Hsu C. Use and interpretation of cardiac troponins in the ED. Am J Emerg Med 2008; 26 (3): 331-341.
- Smith S.C., Ladenson J.H., Mason J.W., Jaffe A.S. Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation 1997; 95 (1): 163-168.
- Zaichik A., Churilov L.P., Utekhin V.J. Autoimmune regulation of genetically determined cell functions in health and disease. Pathophysiology 2008; 15 (3): 191-207.
- Caforio A.L.P., Tona F., Bottaro S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 2008; 41 (1): 35-45.
- Baba A., Yoshikawa T., Ogawa S. Autoantibodies against sarcolemmal Na-K-ATPase: Possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40 (6): 1153-1159.
- Caforio A.L.P., Mahon N.G., Baig M.K. et al. Prospective familial assessment in dilated cardiomyopathy: Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115: 76-83.
- Iwata M., Yoshikawa T., Baba A. et al. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37 (2): 418-424.
- Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991; 147 (7): 2141-2147.
- Fairweather D., Frisancho-Kiss S., Njoku D.B. Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1Β, and Immune Complex Deposition in the Heart. J Immunol 2006; 176 (6): 3516-3524.
- Portig I., Sandmoeller A., Kreilinger S., Maisch B. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 2009; 42 (1): 33-40.
- Staudt A., Bohm M., Knebel F. et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106 (19): 2448-2453.
- Kallwellis-Opara A., Dörner A., Poller W.C. et al. Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 2007; 96 (7): 469-480.
- Kaya Z., Katus H.A., Rose N.R. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 2010; 134 (1): 80-88.
![](/img/style/loading.gif)